Atul Khullar, MD, FRCPC

In this letter, doctors describe their experiences with use of sublingual ketamine in a clinical setting and possible us of it as a treatment for depression.

Delayed depression treatment is associated with poorer clinical outcomes. This review highlights the evidence for a more rapid, individualized treatment approach to improve outcomes for individual patients.